MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
51.73
+1.91 (3.83%)
Nov 21, 2024, 1:52 PM EST - Market open

MLTX Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
375.66451.1739.518.04
Short-Term Investments
118.2759.8432.61-
Cash & Short-Term Investments
493.92511.0172.118.04
Cash Growth
-0.41%608.60%797.08%-
Other Receivables
2.411.060.220.15
Receivables
2.411.060.220.15
Prepaid Expenses
15.982.14.181.45
Total Current Assets
512.32514.1776.519.64
Property, Plant & Equipment
3.833.950.330.05
Other Long-Term Assets
2.068.42--
Total Assets
518.21526.5476.849.68
Accounts Payable
0.140.260.160.03
Accrued Expenses
18.018.147.244.76
Short-Term Debt
---15
Current Portion of Leases
1.441.20.15-
Current Income Taxes Payable
0.480.370.110.06
Other Current Liabilities
---1.23
Total Current Liabilities
20.089.977.6721.09
Long-Term Leases
1.942.50.13-
Total Liabilities
22.7113.058.0821.33
Common Stock
0.010.010.010.04
Additional Paid-In Capital
675.34609.97129.1942.06
Retained Earnings
-189.99-116.66-80.65-53.64
Treasury Stock
----0.01
Comprehensive Income & Other
2.832.360.35-0.17
Total Common Equity
488.2495.6848.9-11.72
Minority Interest
7.3117.8219.87-
Shareholders' Equity
495.5513.4968.77-11.65
Total Liabilities & Equity
518.21526.5476.849.68
Total Debt
3.383.70.2815
Net Cash (Debt)
490.54507.3171.83-6.96
Net Cash Growth
-1.06%606.24%--
Net Cash Per Share
7.9010.332.45-0.89
Filing Date Shares Outstanding
63.0662.8739.150.3
Total Common Shares Outstanding
63.0560.4738.980.3
Working Capital
492.24504.268.85-11.45
Book Value Per Share
7.748.201.25-38.57
Tangible Book Value
488.2495.6848.9-11.72
Tangible Book Value Per Share
7.748.201.25-38.57
Source: S&P Capital IQ. Standard template. Financial Sources.